Does the media refer more to INMD or CNXU?

In the previous week, Conexeu Sciences had 1 more articles in the media than InMode. MarketBeat recorded 4 mentions for Conexeu Sciences and 3 mentions for InMode. InMode's average media sentiment score of 1.01 beat Conexeu Sciences' score of 0.75 indicating that InMode is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Conexeu Sciences 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to AVR or CNXU?

In the previous week, Anteris Technologies Global had 21 more articles in the media than Conexeu Sciences. MarketBeat recorded 25 mentions for Anteris Technologies Global and 4 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.75 beat Anteris Technologies Global's score of 0.39 indicating that Conexeu Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 10 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral Conexeu Sciences 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CNXU or SIBN?

In the previous week, SiBone had 4 more articles in the media than Conexeu Sciences. MarketBeat recorded 8 mentions for SiBone and 4 mentions for Conexeu Sciences. SiBone's average media sentiment score of 0.98 beat Conexeu Sciences' score of 0.75 indicating that SiBone is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SiBone 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CNXU or CBLL?

In the previous week, CeriBell had 12 more articles in the media than Conexeu Sciences. MarketBeat recorded 16 mentions for CeriBell and 4 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.75 beat CeriBell's score of 0.30 indicating that Conexeu Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CeriBell 5 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Conexeu Sciences (CNXU) Competitors

$7.31 -0.13 (-1.75%)

As of 04:00 PM Eastern

Compare

CNXU vs. INMD, AVR, SIBN, SSII, and CBLL

Should you buy Conexeu Sciences stock or one of its competitors? Conexeu Sciences's main competitors and comparable companies include InMode (INMD), Anteris Technologies Global (AVR), SiBone (SIBN), SS Innovations International (SSII), and CeriBell (CBLL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Conexeu Sciences compare to InMode?

InMode (NASDAQ:INMD) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment.

InMode currently has a consensus price target of $16.00, suggesting a potential upside of 5.06%. Conexeu Sciences has a consensus price target of $20.00, suggesting a potential upside of 173.60%. Given Conexeu Sciences' stronger consensus rating and higher possible upside, analysts clearly believe Conexeu Sciences is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

InMode has higher revenue and earnings than Conexeu Sciences. Conexeu Sciences is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$370.49M	2.36	$93.83M	$1.23	12.38
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.11	N/A

68.0% of InMode shares are held by institutional investors. 6.9% of InMode shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

InMode has a net margin of 20.69% compared to Conexeu Sciences' net margin of 0.00%. InMode's return on equity of 11.99% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	20.69%	11.99%	10.60%
Conexeu Sciences	N/A	N/A	N/A

In the previous week, Conexeu Sciences had 1 more articles in the media than InMode. MarketBeat recorded 4 mentions for Conexeu Sciences and 3 mentions for InMode. InMode's average media sentiment score of 1.01 beat Conexeu Sciences' score of 0.75 indicating that InMode is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InMode	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Conexeu Sciences	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

InMode beats Conexeu Sciences on 9 of the 12 factors compared between the two stocks.

How does Conexeu Sciences compare to Anteris Technologies Global?

Anteris Technologies Global (NASDAQ:AVR) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

Conexeu Sciences has lower revenue, but higher earnings than Anteris Technologies Global. Conexeu Sciences is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	452.04	-$94.14M	-$2.23	N/A
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.11	N/A

Conexeu Sciences has a net margin of 0.00% compared to Anteris Technologies Global's net margin of -4,619.27%. Conexeu Sciences' return on equity of 0.00% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-4,619.27%	-110.36%	-92.25%
Conexeu Sciences	N/A	N/A	N/A

In the previous week, Anteris Technologies Global had 21 more articles in the media than Conexeu Sciences. MarketBeat recorded 25 mentions for Anteris Technologies Global and 4 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.75 beat Anteris Technologies Global's score of 0.39 indicating that Conexeu Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	10 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral
Conexeu Sciences	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Anteris Technologies Global currently has a consensus price target of $16.00, suggesting a potential upside of 80.38%. Conexeu Sciences has a consensus price target of $20.00, suggesting a potential upside of 173.60%. Given Conexeu Sciences' higher possible upside, analysts clearly believe Conexeu Sciences is more favorable than Anteris Technologies Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Conexeu Sciences beats Anteris Technologies Global on 7 of the 11 factors compared between the two stocks.

How does Conexeu Sciences compare to SiBone?

Conexeu Sciences (NASDAQ:CNXU) and SiBone (NASDAQ:SIBN) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability.

Conexeu Sciences has higher earnings, but lower revenue than SiBone. Conexeu Sciences is trading at a lower price-to-earnings ratio than SiBone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.11	N/A
SiBone	$200.93M	4.19	-$18.90M	-$0.34	N/A

Conexeu Sciences has a net margin of 0.00% compared to SiBone's net margin of -6.85%. Conexeu Sciences' return on equity of 0.00% beat SiBone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
SiBone	-6.85%	-8.23%	-6.07%

In the previous week, SiBone had 4 more articles in the media than Conexeu Sciences. MarketBeat recorded 8 mentions for SiBone and 4 mentions for Conexeu Sciences. SiBone's average media sentiment score of 0.98 beat Conexeu Sciences' score of 0.75 indicating that SiBone is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SiBone	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Conexeu Sciences currently has a consensus target price of $20.00, suggesting a potential upside of 173.60%. SiBone has a consensus target price of $24.17, suggesting a potential upside of 27.19%. Given Conexeu Sciences' higher probable upside, analysts plainly believe Conexeu Sciences is more favorable than SiBone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

98.1% of SiBone shares are owned by institutional investors. 4.0% of SiBone shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

SiBone beats Conexeu Sciences on 7 of the 13 factors compared between the two stocks.

How does Conexeu Sciences compare to SS Innovations International?

Conexeu Sciences (NASDAQ:CNXU) and SS Innovations International (NASDAQ:SSII) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

Conexeu Sciences has a net margin of 0.00% compared to SS Innovations International's net margin of -20.69%. Conexeu Sciences' return on equity of 0.00% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
SS Innovations International	-20.69%	-23.00%	-13.18%

In the previous week, Conexeu Sciences had 2 more articles in the media than SS Innovations International. MarketBeat recorded 4 mentions for Conexeu Sciences and 2 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 1.43 beat Conexeu Sciences' score of 0.75 indicating that SS Innovations International is being referred to more favorably in the news media.

Company	Overall Sentiment
Conexeu Sciences	Positive
SS Innovations International	Positive

Conexeu Sciences has higher earnings, but lower revenue than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than Conexeu Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.11	N/A
SS Innovations International	$42.49M	17.38	-$12.13M	-$0.05	N/A

Conexeu Sciences currently has a consensus price target of $20.00, suggesting a potential upside of 173.60%. SS Innovations International has a consensus price target of $7.00, suggesting a potential upside of 89.70%. Given Conexeu Sciences' stronger consensus rating and higher possible upside, equities analysts plainly believe Conexeu Sciences is more favorable than SS Innovations International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Conexeu Sciences beats SS Innovations International on 8 of the 11 factors compared between the two stocks.

How does Conexeu Sciences compare to CeriBell?

Conexeu Sciences (NASDAQ:CNXU) and CeriBell (NASDAQ:CBLL) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

Conexeu Sciences presently has a consensus price target of $20.00, indicating a potential upside of 173.60%. CeriBell has a consensus price target of $22.00, indicating a potential downside of 3.97%. Given Conexeu Sciences' higher probable upside, equities analysts clearly believe Conexeu Sciences is more favorable than CeriBell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
CeriBell	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83

Conexeu Sciences has higher earnings, but lower revenue than CeriBell. Conexeu Sciences is trading at a lower price-to-earnings ratio than CeriBell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.11	N/A
CeriBell	$89.06M	9.87	-$53.41M	-$1.63	N/A

In the previous week, CeriBell had 12 more articles in the media than Conexeu Sciences. MarketBeat recorded 16 mentions for CeriBell and 4 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.75 beat CeriBell's score of 0.30 indicating that Conexeu Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CeriBell	5 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Conexeu Sciences has a net margin of 0.00% compared to CeriBell's net margin of -64.73%. Conexeu Sciences' return on equity of 0.00% beat CeriBell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
CeriBell	-64.73%	-43.02%	-34.53%

Summary

Conexeu Sciences beats CeriBell on 7 of the 12 factors compared between the two stocks.

Get Conexeu Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNXU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNXU vs. The Competition

Export

Metric	Conexeu Sciences	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$199.08M	$5.85B	$7.04B	$12.94B
Dividend Yield	N/A	1.77%	2.58%	10.33%
P/E Ratio	N/A	25.30	268.83	25.29
Price / Sales	N/A	66.55	590.34	79.66
Price / Cash	N/A	33.38	72.26	50.42
Price / Book	N/A	5.82	13.16	6.23
Net Income	-$3.92M	$148.67M	$3.45B	$347.40M
7 Day Performance	-18.69%	2.03%	2.02%	1.46%
1 Month Performance	-28.33%	1.82%	-0.23%	-0.49%
1 Year Performance	N/A	9.05%	70.60%	20.91%

Conexeu Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNXU Conexeu Sciences	3.5073 of 5 stars	$7.31 -1.7%	$20.00 +173.6%	N/A	$199.08M	N/A	N/A	4	News Coverage
INMD InMode	1.9941 of 5 stars	$15.31 +1.3%	$16.00 +4.5%	+9.7%	$869.11M	$370.49M	12.45	480	Positive News Earnings Report
AVR Anteris Technologies Global	2.888 of 5 stars	$8.91 +6.6%	$16.00 +79.6%	+162.0%	$813.78M	$1.91M	N/A	138	Trending News Earnings Report Insider Trade
SIBN SiBone	3.3017 of 5 stars	$18.61 +2.6%	$24.29 +30.5%	+22.1%	$804.50M	$200.93M	N/A	350
SSII SS Innovations International	2.6462 of 5 stars	$3.77 +1.6%	$7.00 +85.7%	-42.2%	$742.49M	$42.49M	N/A	4	Positive News Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CNXU) was last updated on 8/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Conexeu Sciences (CNXU) Competitors

CNXU vs. INMD, AVR, SIBN, SSII, and CBLL

How does Conexeu Sciences compare to InMode?

Summary

How does Conexeu Sciences compare to Anteris Technologies Global?

Summary

How does Conexeu Sciences compare to SiBone?

Summary

How does Conexeu Sciences compare to SS Innovations International?

Summary

How does Conexeu Sciences compare to CeriBell?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNXU vs. The Competition

Conexeu Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Conexeu Sciences (CNXU) Competitors

CNXU vs. INMD, AVR, SIBN, SSII, and CBLL

How does Conexeu Sciences compare to InMode?

Do analysts recommend INMD or CNXU?

Which has better earnings & valuation, INMD or CNXU?

Do insiders and institutionals have more ownership in INMD or CNXU?

Is INMD or CNXU more profitable?

Does the media refer more to INMD or CNXU?

Summary

How does Conexeu Sciences compare to Anteris Technologies Global?

Which has better valuation and earnings, AVR or CNXU?

Is AVR or CNXU more profitable?

Does the media refer more to AVR or CNXU?

Do analysts prefer AVR or CNXU?

Summary

How does Conexeu Sciences compare to SiBone?

Which has stronger earnings & valuation, CNXU or SIBN?

Is CNXU or SIBN more profitable?

Does the media refer more to CNXU or SIBN?

Do analysts prefer CNXU or SIBN?

Do institutionals and insiders have more ownership in CNXU or SIBN?

Summary

How does Conexeu Sciences compare to SS Innovations International?

Is CNXU or SSII more profitable?

Does the media refer more to CNXU or SSII?

Which has preferable earnings and valuation, CNXU or SSII?

Do analysts prefer CNXU or SSII?

Summary

How does Conexeu Sciences compare to CeriBell?

Do analysts recommend CNXU or CBLL?

Which has higher earnings and valuation, CNXU or CBLL?

Does the media favor CNXU or CBLL?

Is CNXU or CBLL more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNXU vs. The Competition

Conexeu Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools